Medacta Group
CHF 113.40Change from previous close: −0.18%Absolute change: −CHF 0.20
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- CHF 2.26B
- Enterprise value
- CHF 2.55B
- P/E (trailing 12 months)
- 31.0
- Forward P/E
- 21.1
- Price/book
- 4.94
- Price/sales
- 3.20
- EV/EBITDA
- 15.0
- EV/revenue
- 3.60
Profitability and growth
- Gross margin
- 65.5%
- Operating margin
- 15.0%
- Net margin
- 10.9%
- ROE
- 17.0%
- ROA
- 7.2%
- Revenue growth (year over year)
- 7.0%
- Earnings growth (year over year)
- -30.2%
Financial health
- Total cash
- CHF 35.99M
- Total debt
- CHF 320.58M
- Debt/equity
- 0.66
- Current ratio
- 2.10
- Quick ratio
- 0.74
Dividends
- Annual dividend per share
- CHF 1.10
- Dividend yield
- 1.0%
- Payout ratio
- 30.8%
- Ex-dividend date
- May 7, 2026
Analysts and estimates
- Average price target
- CHF 160.38
- Median price target
- CHF 163.37
- High price target
- CHF 190.14
- Low price target
- CHF 119.56
- Analysts with a price target
- 6
- Forward EPS
- CHF 5.37
- EPS estimate, current year
- CHF 4.76
Shares and trading
- Beta
- 0.97
- Average volume
- 29.49K
- Shares outstanding
- 19.95M
- Float
- 6.03M
- Institutional ownership
- 11.9%
- Insider ownership
- 69.7%